about
Associations of Prostate-Specific Antigen, Prostate Carcinoma Tissue Gleason Score, and Androgen Receptor Expression with Bone Metastasis in Patients with Prostate CarcinomaHigh incidence of prostate cancer metastasis in Afro-Brazilian men with low educational levels: a retrospective observational study.Lineage analysis of basal epithelial cells reveals their unexpected plasticity and supports a cell-of-origin model for prostate cancer heterogeneityThe roots of cancer: stem cells and the basis for tumor heterogeneity.Novel approaches for the identification of biomarkers of aggressive prostate cancerThe prognostic value of reactive stroma on prostate needle biopsy: a population-based study.Role of mpMRI of the prostate in screening for prostate cancer.Combining lymphovascular invasion with reactive stromal grade predicts prostate cancer mortality.Identification of a cyclin D1 network in prostate cancer that antagonizes epithelial-mesenchymal restraint.Integrated Classification of Prostate Cancer Reveals a Novel Luminal Subtype with Poor Outcome.First off-time treatment prostate-specific antigen kinetics predicts survival in intermittent androgen deprivation for prostate cancer.CCL11 (eotaxin-1): a new diagnostic serum marker for prostate cancerBiomarkers to guide therapy or surveillance for prostate cancer.TWIST overexpression predicts biochemical recurrence-free survival in prostate cancer patients treated with radical prostatectomy.Psychometric properties of the expanded prostate cancer index composite - 26 instrument in a cohort of radical prostatectomy patients: theoretical and practical examinations.Health Economic Impact and Prospective Clinical Utility of Oncotype DX® Genomic Prostate Score.DNA methyltransferase 3b (DNMT3b), tumor tissue DNA methylation, Gleason score, and prostate cancer mortality: investigating causal relationships
P2860
Q33584215-6ADE3D57-F493-4EB3-8708-3EEB4B3F4566Q34756185-D2FAF1BB-5062-4770-86B8-13BC127908CDQ37094872-D77019E6-9353-40F6-957D-D4F73CFA2D3DQ38048655-2AB5B234-CADD-4143-9B1D-E94DDA793150Q38117841-5EC71FC4-E956-4CC4-B624-74890A3B0AF0Q38332303-7E5755E7-C5BE-45AE-9B82-3F7FF7682039Q38671170-6F36E462-9885-479B-AE07-D7924E7553AFQ38857954-120D6AB8-1F79-4FBC-8056-0248BEC6CB9AQ39053619-3FA836FE-B6F5-41CE-A592-78A80949A0C0Q39683347-0CF15DE1-603F-4363-93ED-5D229EEF21BDQ41188480-868BC944-C502-4C01-90E8-B0B5F82FA391Q41281281-3B3ADE15-F67E-449A-B456-A8562BC35EF4Q45810868-359B46E7-F1E5-46E1-8443-FDEDEFF925CBQ46831086-CAAA9723-8960-4842-ADDD-93F5A2A6A7DBQ47142153-184ED5E3-CCB0-41DA-B026-699F6352D155Q50550236-9D85D492-70A2-4976-85F2-BDD0F08B798CQ57151790-42FEE3A5-DCDC-42B7-8714-D6ED43D5CB7A
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Prognostic determinants in prostate cancer.
@en
Prognostic determinants in prostate cancer.
@nl
type
label
Prognostic determinants in prostate cancer.
@en
Prognostic determinants in prostate cancer.
@nl
prefLabel
Prognostic determinants in prostate cancer.
@en
Prognostic determinants in prostate cancer.
@nl
P2860
P1433
P1476
Prognostic determinants in prostate cancer.
@en
P2093
Neil E Martin
Ronald A Depinho
P2860
P304
P356
10.1097/PPO.0B013E31823B042C
P577
2011-11-01T00:00:00Z